Consumption, production and distribution impacted by COVID-19 in bothMalaysia and Singapore. Quarterly dividend payment suspended to beprudent on cash and liquidity
SHAH ALAM, 29 May...
Kuala Lumpur, 15 January 2026 – Novo Nordisk today announced the availability of Wegovy® (semaglutide 2.4 mg) (MAL24126014AZ) in Malaysia, an adjunct treatment option...